Proteomics of endometrial cancer diagnosis, treatment, and prognosis

Files

hdl_99849.pdf (1.03 MB)
  (Accepted version)

Date

2016

Authors

Mittal, P.
Klingler-Hoffmann, M.
Arentz, G.
Zhang, C.
Kaur, G.
Oehler, M.
Hoffmann, P.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

Proteomics - Clinical Applications, 2016; 10(3):217-229

Statement of Responsibility

Parul Mittal, Manuela Klingler-Hoffmann, Georgia Arentz, Chao Zhang, Gurjeet Kaur, Martin K. Oehler, and Peter Hoffmann

Conference Name

Abstract

This review discusses the current status of proteomics technology in endometrial cancer diagnosis, treatment and prognosis. The first part of this review focuses on recently identified biomarkers for endometrial cancer, their importance in clinical use as well as the proteomic methods used in their discovery. The second part highlights some of the emerging mass spectrometry based proteomic technologies that promise to contribute to a better understanding of endometrial cancer by comparing the abundance of hundreds or thousands of proteins simultaneously.

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim

License

Grant ID

Call number

Persistent link to this record